Alex Loftis
Principal Vida Ventures
Alex is a Principal at Vida Ventures in Los Angeles, where he focuses on private and public investing in immunology and oncology. He currently serves as a director on the board of InduPro, and was instrumental in Vida’s investments in Avalyn Pharma, Phylaxis BioScience, Tango Therapeutics, and Maze Therapeutics. He joined the firm in 2022.
Seminars
The biopharmaceutical sector continues to innovate peptide discovery innovations, from new macrocycles to new delivery methods and are thriving on strategic alliances, which allow for cross-functional sharing of knowledge, and experience to advance peptide drugs to patients faster. Hear first-hand how investors and key biotechs are keeping up with the peptide momentum through investments, alliances and collaborations.
Key questions to be addressed include:
- How to strategize the complexities, risks and decision-making strategies for choosing the right platform to invest and advance innovative approaches in the peptide industry?
- What are the key areas and spaces that peptides can fill in the biotechnology sector?
- What does it take for a small biotech to survive and get noticed from an investor or big pharma?
